Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Shanghai Fosun Pharmaceutical (Group) Co., Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2022 is 8.77% vs 38.19% in Dec 2021",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2022 is -23.34% vs 35.47% in Dec 2021",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "50,947.30",
          "val2": "46,839.50",
          "chgp": "8.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6,552.70",
          "val2": "5,129.80",
          "chgp": "27.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1,120.80",
          "val2": "991.30",
          "chgp": "13.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-160.90",
          "val2": "-728.20",
          "chgp": "77.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4,597.60",
          "val2": "5,997.50",
          "chgp": "-23.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "72.80%",
          "val2": "59.40%",
          "chgp": "1.34%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'22

Dec'22

Dec'21

Change(%)

Net Sales

50,947.30

46,839.50

8.77%

Operating Profit (PBDIT) excl Other Income

6,552.70

5,129.80

27.74%

Interest

1,120.80

991.30

13.06%

Exceptional Items

-160.90

-728.20

77.90%

Consolidate Net Profit

4,597.60

5,997.50

-23.34%

Operating Profit Margin (Excl OI)

72.80%

59.40%

1.34%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2022 is 8.77% vs 38.19% in Dec 2021

Consolidated Net Profit

YoY Growth in year ended Dec 2022 is -23.34% vs 35.47% in Dec 2021

All Annual Results